Free Trial Information
BioCentury | Mar 23, 2009
Company News

CG Therapeutics management update

CG Therapeutics Inc. , Seattle, Wash. Business: Cancer Promoted: Denise Harrison to president and CEO from CFO; she replaces Jonathan Green WIR Staff cancer...
Read More
BioCentury | Apr 7, 2008
Company News

CG Therapeutics, University of Washington deal

...that is in Phase II testing to treat solid tumors. Financial terms were not disclosed. CG Therapeutics Inc....
Read More
BioCentury | Mar 10, 2008
Emerging Company Profile

Corporate Profile

...Corporate Profile CG Therapeutics Inc. Seattle, Wash. Technology: Vaccines and mAbs Disease focus: Cancer Clinical status: Phase II...
Read More
BioCentury | Mar 10, 2008
Emerging Company Profile

CG Therapeutics: Hormone neutralizer

...While most cancer vaccines aim to stimulate the immune system to boost T cell production, CG Therapeutics Inc....
...seeking partners for further testing. COMPANIES AND INSTITUTIONS MENTIONED AVI Biopharma Inc. (NASDAQ:AVII), Portland, Ore. CG Therapeutics Inc....
Read More
BioCentury | Sep 24, 2007
Company News

CG Therapeutics board of directors update

CG Therapeutics Inc. , Seattle, Wash. Business: Cancer Appointed: Christopher Henney, chairman of Biomira Inc. and SGX Pharmaceuticals Inc. , as chairman WIR Staff cancer...
Read More
Items per page:
1 - 5 of 5
BioCentury | Mar 23, 2009
Company News

CG Therapeutics management update

CG Therapeutics Inc. , Seattle, Wash. Business: Cancer Promoted: Denise Harrison to president and CEO from CFO; she replaces Jonathan Green WIR Staff cancer...
Read More
BioCentury | Apr 7, 2008
Company News

CG Therapeutics, University of Washington deal

...that is in Phase II testing to treat solid tumors. Financial terms were not disclosed. CG Therapeutics Inc....
Read More
BioCentury | Mar 10, 2008
Emerging Company Profile

Corporate Profile

...Corporate Profile CG Therapeutics Inc. Seattle, Wash. Technology: Vaccines and mAbs Disease focus: Cancer Clinical status: Phase II...
Read More
BioCentury | Mar 10, 2008
Emerging Company Profile

CG Therapeutics: Hormone neutralizer

...While most cancer vaccines aim to stimulate the immune system to boost T cell production, CG Therapeutics Inc....
...seeking partners for further testing. COMPANIES AND INSTITUTIONS MENTIONED AVI Biopharma Inc. (NASDAQ:AVII), Portland, Ore. CG Therapeutics Inc....
Read More
BioCentury | Sep 24, 2007
Company News

CG Therapeutics board of directors update

CG Therapeutics Inc. , Seattle, Wash. Business: Cancer Appointed: Christopher Henney, chairman of Biomira Inc. and SGX Pharmaceuticals Inc. , as chairman WIR Staff cancer...
Read More
Items per page:
1 - 5 of 5